Molecular Templates, Inc. announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 â December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX.Molecular Templates will also participate in one-on-one meetings at the 64thAmerican Society of Hematology (ASH) Annual Meeting which will take place December 10 â December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person and virtual meetings may be scheduled directly with Molecular Templates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -3.33% | -2.03% | -61.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.13% | 9.55M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.56% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- MTEM Stock
- News Molecular Templates, Inc.
- Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium and Participate at the 64th American Society of Hematology Annual Meeting